Your search returned 3 results.

Results
	1.	Current insight in the localized insulin-derived amyloidosis (LIDA): clinico-pathological characteristics and differential diagnosis. [Review] MedStar authors: Ansari, Amir Mehdi Matsangos, Aerielle E PMID: 28935176 Year: 2017 Citation: Pathology, Research & Practice. 213(10):1237-1241, 2017 Oct. Institution: MedStar Union Memorial Hospital Department: Internal Medicine Medline publication type: Journal Article Review Form of publication: Journal Article All authors: Ansari AM, Li QK, Matsangos AE, Osmani L DOI: https://dx.doi.org/10.1016/j.prp.2017.08.013 Add to cart (remove)
	2.	Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial. MedStar authors: Aroda, Vanita R PMID: 29246950 Year: 2018 Citation: Diabetes Care. 41(2):258-266, 2018 02. Institution: MedStar Health Research Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Ahmann AJ, Annett MP, Aroda VR, Capehorn M, Charpentier G, Dotta F, Henkel E, Holst AG, Lingvay I DOI: https://dx.doi.org/10.2337/dc17-0417 Add to cart (remove)
	3.	Evaluation of in-stent restenosis in the APPROACH trial (Assessment on the Prevention of Progression by Rosiglitazone On Atherosclerosis in diabetes patients with Cardiovascular History). MedStar authors: Ratner, Robert E PMID: 21359834 Year: 2012 Citation: The International Journal of Cardiovascular Imaging. 28(3):455-65, 2012 Mar. Institution: MedStar Health Research Institute Medline publication type: Comparative Study Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: APPROACH study group, Brugaletta S, Garcia-Garcia HM, Garg S, Huang C, Kolatkar NS, Kravitz BG, Miller DM, Morocutti G, Nesto RW, Ratner RE, Serruys PW DOI: http://dx.doi.org/10.1007/s10554-011-9836-z Add to cart (remove)

Powered by Koha